(c) 2012 Wiley Periodicals, Inc.”
“Study Design. A case report
with systematic review of the literature.\n\nObjective. To report a case of post-traumatic C4-C5 spondyloptosis without neurological deficit not associated with posterior element fractures and presenting in a delayed fashion with fusion in situ of C4 and C5 vertebral bodies influencing the management strategy.\n\nSummary of Background Data. Traumatic spondyloptosis of the subaxial cervical spine is typically associated with neurological injury. To the best of the author’s knowledge, this is the first case of spondyloptosis not associated with fractures of the posterior elements but with locked facets at C4-C5 and fusion in situ, presenting in a delayed fashion with remarkable paucity of symptoms that was managed surgically.\n\nMethods. A 45-year-old male presented 8 months after 3-deazaneplanocin A a motor vehicle collision with radicular arm pain and mild spasticity involving the legs. Cervical radiograph, computed tomographic scan, and magnetic resonance image revealed bilateral locked facets at C4-C5 with spondyloptosis. Fusion had occurred in situ.\n\nResults. Traction did not correct alignment and the patient underwent circumferential reduction and fusion and postoperative Vorinostat purchase halo-vest placement. At 6-month follow-up, the patient remained neurologically intact with regression of preoperative symptoms.\n\nConclusion. Longstanding
post-traumatic spondyloptosis may lead to fusion in situ complicating the surgical management. Insufficient suspicion during workup can lead to the omission of this important diagnosis, further complicating operative intervention. Traction is not useful when in situ fusion has occurred in delayed presentation cases.”
“P>Background:\n\nHigh-dose single-shot caudal morphine has been postulated to facilitate early extubation and to lower initial analgesic requirements after staged single-ventricle (SV) palliation.\n\nMethods:\n\nWith Selleck Bcl2 inhibitor Institutional Review Board approval and written informed parental consent, 64 SV children aged 75-1667 days were randomized to pre-incisional caudal morphine-bupivacaine (100 mu g center dot kg-1 morphine (concentration 0.1%), mixed with 0.25%
bupivacaine with 1 : 200 000 epinephrine, total 1 ml center dot kg-1) and postcardiopulmonary bypass (CPB) intravenous (IV) droperidol (75 mu g center dot kg-1) (‘active caudal group’) or pre-incisional caudal saline (1 ml center dot kg-1) and post-CPB IV morphine (150 mu g center dot kg-1) with droperidol (75 mu g center dot kg-1) (‘active IV group’). Assignment remained concealed from families and the care teams throughout the trial. Early extubation failure rates (primary or reintubation within 24 h), time to first postoperative rescue morphine analgesia, and 12-h postoperative morphine requirements were assessed for extubated patients.\n\nResults:\n\nThirty-one (12 stage 2) SV patients received caudal morphine and 32 (15 stage 2) received IV morphine.